-- Scott Roberts
WEDNESDAY, April 13 (HealthDay News) -- A new option to repair a
difficult-to-manage bulging artery in the brain has been approved
by the U.S. Food and Drug Administration.
Such a bulge, called an aneurysm, can grow and eventually burst.
This can lead to a brain hemorrhage and even death.
Aneurysms larger than 10 millimeters, or those of an odd shape,
often are difficult to treat. The cPAX Aneurysm Treatment System
uses a special polymer to line the artery around the aneurysm,
reducing the risk of rupture, the FDA said in a news release.
The system was approved under the agency's Humanitarian Device
Exemption, which makes devices available for conditions affecting
fewer than 4,000 people annually. The system was evaluated in small
pair of clinical studies involving 43 people, the FDA said.
The cPAX system was approved for people 22 and older. It
shouldn't be used in people with an active infection or among those
who can't undergo anti-clotting therapy, the agency said.
The system is manufactured by Neurovasx Inc., of Maple Grove,
The FDA has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.